Effects of low-dose aspirin on serum C-reactive protein and thromboxane B2 concentrations: A placebo-controlled study using a highly sensitive C-reactive protein assay

Journal of the American College of Cardiology

Volumn 37, Issue 8, 2001, Pages 2036-2041

  Feldman, Mark ^a,b   Jialal, Ishwarlal ^b   Devaraj, Sridevi ^b   Cryer, Byron ^a,b  

^a VA NORTH TEXAS HEALTH CARE SYSTEM   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; C REACTIVE PROTEIN; CYCLOOXYGENASE 1; THROMBOXANE B2;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; HUMAN EXPERIMENT; MALE; NEPHELOMETRY; PRIORITY JOURNAL; RADIOIMMUNOASSAY; RANDOMIZED CONTROLLED TRIAL;

ADULT; ASPIRIN; C-REACTIVE PROTEIN; DOUBLE-BLIND METHOD; FEMALE; HUMANS; IMMUNOASSAY; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; THROMBOXANE B2;

EID: 0035875796     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(01)01289-X     Document Type: Article

References (18)

1. Atherosclerosis - An inflammatory disease
2. Inflammation, aspirin and the risk of cardiovascular disease in apparently healthy men
3. Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women
4. Increased proinflammatory cytokines in patients with chronic stable angina and their reduction by aspirin
5. Effect of short-term aspirin use on C-reactive protein
6. Aspirin as an antiplatelet drug
7. Aspirin absorption rates and platelet inhibition times with 325-mg buffered aspirin tablets (chewed or swallowed intact) and with buffered aspirin solution
8. Inflammation in cardiovascular disease: Cart, horse or both?
9. CRP and the risks of future myocardial infarction and thrombotic stroke
10. CRP immunochemical localization in normal and atherosclerotic human aortas
11. CRP induces human peripheral blood monocytes to synthesize tissue factor
12. Review: Biology, and relevance of C-reactive protein in cardiovascular and renal disease
13. Inflammatory markers of coronary risk
14. IL-6 and APPs: Anti-inflammatory and immunosuppressive mediators
15. Elevated C-reactive protein levels in overweight and obese adults
16. Inflammation, obesity, stress and coronary heart disease: Is interleukin-6 the link?
17. Evaluation of four automated high-sensitivity C-reactive protein methods: Implications for clinical and epidemiological applications
18. Inhibition of cyclo-oxygenase attenuates the metabolic response to endotoxin in humans